Pretomanid (BPaL Regimen) for Drug-Resistant Tuberculosis: 6-Month Oral Treatment Explained (FDA 2019)
Arikayce (Amikacin Liposome) for Refractory MAC Lung Disease: Inhaled Antibiotic Explained (FDA 2018)
Baxdela (Delafloxacin) for Skin Infections and Pneumonia: The Fluoroquinolone With a Boxed Warning Explained (FDA Approved 2017)
Orbactiv (Oritavancin) for Skin Infections: Single-Dose MRSA Treatment Explained (FDA 2014)
